Go Pro
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel Free EVOXW Stock Alerts

Evox Therapeutics (EVOXW) Competitors

Evox Therapeutics logo
$0.36 -0.03 (-7.41%)
As of 08/13/2026 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

EVOXW vs. AGD, AWP, THQ, ACP, and THW

Should you buy Evox Therapeutics stock or one of its competitors? Evox Therapeutics's main competitors and comparable companies include Abrdn Global Dynamic Dividend Fund (AGD), abrdn Global Premier Properties Fund (AWP), Abrdn Healthcare Opportunities Fund (THQ), Abrdn Income Credit Strategies Fund (ACP), and Abrdn World Healthcare Fund (THW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does Evox Therapeutics compare to Abrdn Global Dynamic Dividend Fund?

Abrdn Global Dynamic Dividend Fund (NYSE:AGD) and Evox Therapeutics (NASDAQ:EVOXW) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

Company Net Margins Return on Equity Return on Assets
Abrdn Global Dynamic Dividend FundN/A N/A N/A
Evox Therapeutics N/A N/A N/A

In the previous week, Abrdn Global Dynamic Dividend Fund had 1 more articles in the media than Evox Therapeutics. MarketBeat recorded 2 mentions for Abrdn Global Dynamic Dividend Fund and 1 mentions for Evox Therapeutics. Evox Therapeutics' average media sentiment score of 1.87 beat Abrdn Global Dynamic Dividend Fund's score of 1.00 indicating that Evox Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Abrdn Global Dynamic Dividend Fund Positive
Evox Therapeutics Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abrdn Global Dynamic Dividend Fund$75.72MN/AN/AN/AN/A
Evox TherapeuticsN/AN/AN/AN/AN/A

Summary

Abrdn Global Dynamic Dividend Fund beats Evox Therapeutics on 2 of the 3 factors compared between the two stocks.

How does Evox Therapeutics compare to abrdn Global Premier Properties Fund?

abrdn Global Premier Properties Fund (NYSE:AWP) and Evox Therapeutics (NASDAQ:EVOXW) are both finance companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
abrdn Global Premier Properties Fund$60.73MN/AN/AN/AN/A
Evox TherapeuticsN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
abrdn Global Premier Properties FundN/A N/A N/A
Evox Therapeutics N/A N/A N/A

In the previous week, abrdn Global Premier Properties Fund and abrdn Global Premier Properties Fund both had 1 articles in the media. Evox Therapeutics' average media sentiment score of 1.87 beat abrdn Global Premier Properties Fund's score of 1.00 indicating that Evox Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
abrdn Global Premier Properties Fund Positive
Evox Therapeutics Very Positive

Summary

abrdn Global Premier Properties Fund and Evox Therapeutics tied by winning 1 of the 2 factors compared between the two stocks.

How does Evox Therapeutics compare to Abrdn Healthcare Opportunities Fund?

Evox Therapeutics (NASDAQ:EVOXW) and Abrdn Healthcare Opportunities Fund (NYSE:THQ) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, media sentiment, dividends and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evox TherapeuticsN/AN/AN/AN/AN/A
Abrdn Healthcare Opportunities Fund-$28.02MN/AN/AN/AN/A

In the previous week, Abrdn Healthcare Opportunities Fund had 1 more articles in the media than Evox Therapeutics. MarketBeat recorded 2 mentions for Abrdn Healthcare Opportunities Fund and 1 mentions for Evox Therapeutics. Evox Therapeutics' average media sentiment score of 1.87 beat Abrdn Healthcare Opportunities Fund's score of 1.00 indicating that Evox Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Evox Therapeutics Very Positive
Abrdn Healthcare Opportunities Fund Positive

Company Net Margins Return on Equity Return on Assets
Evox TherapeuticsN/A N/A N/A
Abrdn Healthcare Opportunities Fund N/A N/A N/A

Summary

Evox Therapeutics beats Abrdn Healthcare Opportunities Fund on 2 of the 3 factors compared between the two stocks.

How does Evox Therapeutics compare to Abrdn Income Credit Strategies Fund?

Evox Therapeutics (NASDAQ:EVOXW) and Abrdn Income Credit Strategies Fund (NYSE:ACP) are both finance companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation and profitability.

In the previous week, Abrdn Income Credit Strategies Fund had 1 more articles in the media than Evox Therapeutics. MarketBeat recorded 2 mentions for Abrdn Income Credit Strategies Fund and 1 mentions for Evox Therapeutics. Evox Therapeutics' average media sentiment score of 1.87 beat Abrdn Income Credit Strategies Fund's score of 1.00 indicating that Evox Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Evox Therapeutics Very Positive
Abrdn Income Credit Strategies Fund Positive

Company Net Margins Return on Equity Return on Assets
Evox TherapeuticsN/A N/A N/A
Abrdn Income Credit Strategies Fund N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evox TherapeuticsN/AN/AN/AN/AN/A
Abrdn Income Credit Strategies Fund$85.32MN/AN/AN/AN/A

Summary

Abrdn Income Credit Strategies Fund beats Evox Therapeutics on 2 of the 3 factors compared between the two stocks.

How does Evox Therapeutics compare to Abrdn World Healthcare Fund?

Evox Therapeutics (NASDAQ:EVOXW) and Abrdn World Healthcare Fund (NYSE:THW) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evox TherapeuticsN/AN/AN/AN/AN/A
Abrdn World Healthcare Fund$86.53MN/AN/AN/AN/A

In the previous week, Abrdn World Healthcare Fund had 1 more articles in the media than Evox Therapeutics. MarketBeat recorded 2 mentions for Abrdn World Healthcare Fund and 1 mentions for Evox Therapeutics. Evox Therapeutics' average media sentiment score of 1.87 beat Abrdn World Healthcare Fund's score of 1.25 indicating that Evox Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Evox Therapeutics Very Positive
Abrdn World Healthcare Fund Positive

Company Net Margins Return on Equity Return on Assets
Evox TherapeuticsN/A N/A N/A
Abrdn World Healthcare Fund N/A N/A N/A

Summary

Abrdn World Healthcare Fund beats Evox Therapeutics on 2 of the 3 factors compared between the two stocks.

Get Evox Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVOXW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EVOXW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EVOXW vs. The Competition

Export
MetricEvox TherapeuticsCapital Markets IndustryFinance SectorNASDAQ Exchange
Market CapN/A$5.66B$14.05B$12.99B
Dividend YieldN/A7.39%5.88%10.72%
P/E RatioN/A38.6929.5725.23
Price / SalesN/A1,246.98512.77101.16
Price / CashN/A48.3339.9750.75
Price / BookN/A3.733.706.24
Net IncomeN/A$417.15M$1.31B$347.70M
7 Day PerformanceN/A0.82%0.79%0.90%
1 Month PerformanceN/A1.24%1.85%0.91%
1 Year PerformanceN/A7.97%12.20%20.09%

Evox Therapeutics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EVOXW
Evox Therapeutics
N/A$0.40
+1.8%		N/AN/A$0.00N/AN/AN/A
AGD
Abrdn Global Dynamic Dividend Fund
N/A$12.20
-0.2%		N/A+8.5%$0.00$75.72MN/AN/A
AWP
abrdn Global Premier Properties Fund
N/A$11.88
-0.2%		N/A+0.5%$0.00$60.73MN/AN/A
THQ
Abrdn Healthcare Opportunities Fund
N/A$19.22
flat		N/A+21.4%$0.00-$28.02MN/A1,088
ACP
Abrdn Income Credit Strategies Fund
N/A$5.09
+0.1%		N/A-13.9%$0.00$85.32MN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:EVOXW) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Elon’s S-1 Master Plan Could Rewrite the Rules of AI
A researcher who has advised Goldman Sachs, JPMorgan Chase, BlackRock, and Fidelity flew to Starbase after spo...
Altimetry | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Central banks bought 710 tonnes - this fund pays monthly
Gold is hitting new highs, fueled by tariffs and record central bank demand - 710 tonnes per quarter. JPMorgan...
Investors Alley | Sponsoredtc pixel